Our results have potential clinical implications for novel therapeutic strategies targeting immune dysfunction in chronically treated HIV-infected individuals, in particular those with persistent expansion of CD8+ T cells despite adequate CD4+ T cell recovery. This evidence concerns the gene CD8A and immune system disorder.